TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib (HY-10201) to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells[1].
Molecular Weight:
349.25
Purity:
99.66
CAS Number:
[364621-46-5]
Formula:
C15H13BrN2OS
Target:
Apoptosis,Connective Peptide
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
